title: A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.
abstract: Transforming Growth Factor-β (TGF-β) exerts cell type-specific and context-dependent effects. Understanding the intrinsic effects of TGF-β on cancer cells in pancreatic ductal adenocarcinoma (PDAC) is a prerequisite for rationalized clinical implementation of TGF-β targeting therapies. Since the tumor microenvironment can affect how cancer cell respond to TGF-β, we employed a novel three-dimensional (3D) culturing system to recapitulate stromal and extracellular matrix interactions. We show here that TGF-β stimulates growth of human and murine pancreatic cancer cell lines (PCCs) when embedded in a 3% collagen IV/laminin-rich gelatinous medium (Matrigel™) over a solidified layer of soft agar. Moreover, in this novel 3D model, concomitant treatment with TGF-β1 and epidermal growth factor (EGF) enhanced PCC growth to a greater extent than either growth factor alone, and conferred increased chemoresistance to cytotoxic compounds. These cooperative growth-stimulatory effects were blocked by pharmacological inhibition of TGF-β type I receptor with SB431542 or the EGF receptor with erlotinib. Co-incubation with SB431542 and erlotinib enhanced the efficacy of gemcitabine and cisplatin in PCCs and in primary cell cultures established from pancreata of genetically-engineered mouse models of PDAC. These findings suggest that concomitant inhibition of TGF-β and EGF signaling may represent an effective therapeutic strategy in PDAC, and that this 3D culturing system could be utilized to test ex vivo the therapeutic response of pancreatic tumor biopsies from PDAC patients, thereby providing a functional assay to facilitate personalized targeted therapies.
authors: Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA. Lorenzo.F.Sempere@Dartmouth.edu
authors: Lorenzo F
authors: LF
authors: Sempere
authors: Jason R
authors: JR
authors: Gunn
authors: Murray
authors: M
authors: Korc
references: Cancer Cell. 2009 Jun 2;15(6):489-500
references: 19477428
references: Mol Cancer. 2003 Jan 07;2:8
references: 12556241
references: Cancer Biol Ther. 2010 May 15;9(10):754-63
references: 20234186
references: Methods. 2003 Jul;30(3):256-68
references: 12798140
references: Biochem Biophys Res Commun. 1999 Feb 16;255(2):268-73
references: 10049697
references: Oncogene. 1998 Oct 15;17(15):1969-78
references: 9788440
references: Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5947-52
references: 16585505
references: Genes Dev. 2006 Nov 15;20(22):3147-60
references: 17114585
references: Curr Opin Genet Dev. 2006 Feb;16(1):30-7
references: 16377175
references: Cancer Res. 2008 Oct 1;68(19):7707-10
references: 18829522
references: Genes Dev. 2006 Nov 15;20(22):3130-46
references: 17114584
references: Cancer Res. 2006 Jan 1;66(1):95-106
references: 16397221
references: Oncogene. 1999 Sep 23;18(39):5363-72
references: 10498890
references: Annu Rev Pathol. 2008;3:157-88
references: 18039136
references: Nat Rev Immunol. 2010 Aug;10(8):554-67
references: 20616810
references: Nat Rev Cancer. 2010 Jun;10(6):415-24
references: 20495575
references: Mech Dev. 2003 Jan;120(1):35-43
references: 12490294
references: Cancer Res. 2009 Jul 15;69(14):5820-8
references: 19584296
references: J Clin Oncol. 2007 May 20;25(15):1960-6
references: 17452677
references: Clin Cancer Res. 2001 Sep;7(9):2931-40
references: 11555612
references: Cancer Res. 2009 Jan 15;69(2):475-82
references: 19147560
references: Nat Rev Cancer. 2006 Jul;6(7):506-20
references: 16794634
references: Breast Cancer Res Treat. 2010 Jul;122(1):35-43
references: 19701706
references: Virchows Arch. 2001 Dec;439(6):798-802
references: 11787853
references: J Clin Oncol. 2009 Nov 20;27(33):5660-9
references: 19858397
references: Int J Cancer. 1996 Jul 17;67(2):283-8
references: 8760600
references: Virchows Arch. 2003 May;442(5):444-52
references: 12692724
references: Cancer Cell. 2007 Mar;11(3):229-43
references: 17349581
references: Pancreas. 1999 Nov;19(4):370-6
references: 10547197
references: Am J Surg. 2007 Oct;194(4 Suppl):S84-6
references: 17903452
references: Oncogene. 2010 Jun 10;29(23):3335-48
references: 20383197
references: Oncogene. 2008 Apr 10;27(17):2507-12
references: 17952112
references: Gastroenterology. 1993 Dec;105(6):1846-56
references: 8253361
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Mol Cancer Ther. 2002 Jan;1(3):161-7
references: 12467210
references: Mol Cancer Ther. 2007 Apr;6(4):1186-97
references: 17406031
references: Cancer Res. 1998 Dec 1;58(23):5329-32
references: 9850059
references: Biochem Biophys Res Commun. 2007 Jul 6;358(3):698-703
references: 17512909
references: Nat Rev Cancer. 2005 Sep;5(9):675-88
references: 16148884
references: Genes Dev. 2003 Dec 15;17(24):3112-26
references: 14681207
references: Cancer Res. 2009 Jan 15;69(2):422-30
references: 19147554
references: Clin Cancer Res. 2010 Aug 15;16(16):4246-55
references: 20682703
references: Cancer Cell. 2003 Dec;4(6):437-50
references: 14706336
references: Histochem Cell Biol. 2008 Dec;130(6):1105-18
references: 19009245
references: Pancreas. 1999 May;18(4):364-70
references: 10231841